The HIV Prevention Choice Manifesto is a collection of voices of African women and girls in all their diversity, feminists and HIV prevention advocates across Southern and Eastern Africa who are united in calling for continued political and financial support for HIV prevention choice. Biomedical HIV prevention is at a historic turning point, but only if countries and funders heed evidence-based demands that programs must emphasize choice – not individual products – and that research and development of new prevention options continues.
I commit to championing HIV prevention choice for women and girls in Africa by advocating for equitable access to diverse prevention options. I will mobilize resources, influence policy reforms, and promote community-led efforts to empower women, especially in marginalized communities, to make informed health decisions.
I commit to championing HIV prevention choice for women and girls in Africa by advocating for equitable access to diverse prevention options. I will mobilize resources, influence policy reforms, and promote community-led efforts to empower women, especially in marginalized communities, to make informed health decisions.
I am committed to sharing this information with youths in my capacity as a SRH youth advocate and personally in Malawi and in all youth networks am part of as well as with vulnerable and minorities youth populations such as youths in rural areas and LGBTQ youths .I also committee to this manifesto as a Young woman in Africa with Pan African values towards exploring african lead solutions that ensure young girls and women have access to PrEP services and information as well as legislation access via advocacy and research.
The HIV Prevention Choice Manifesto is a collection of voices of African women and girls in all their diversity, feminists and HIV prevention advocates across Southern and Eastern Africa who are united in calling for continued political and financial support for HIV prevention choice. Biomedical HIV prevention is at a historic turning point, but only if countries and funders heed evidence-based demands that programs must emphasize choice – not individual products – and that research and development of new prevention options continues.
